In an era of increasingly individualized healthcare, Elizabeth Philp has emerged as a significant figure of innovation, especially in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a push to make bespoke medications more obtainable, disrupting the standard one-size